Radiation Protection Dosimetry Advance Access first published online on February 3, 2006
This version published online on February 4, 2006
Radiation Protection Dosimetry, doi:10.1093/rpd/nci719
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leuvens Special Issue Article
1 Dipartimento di Fisica, Università di Trieste, Via Valerio 2, 34100 Trieste, Italy; Azienda Ospedaliera S. Maria della Misericordia, 33100 Udine, Italy
* To whom correspondence should be addressed.
The multicentre assessment of a procedure complexity index (CI) for the introduction of reference levels (RLs) in percutaneous transluminal coronary angioplasties (PTCA) is presented here. PTCAs were investigated based on methodology proposed by Bernardi et al. Multiple linear stepwise regression analysis, including clinical, anatomical and technical factors, was performed to obtain fluoroscopy time predictors. Based on these regression coefficients, a scoring system was defined and CI obtained. CI was used to classify dose values into three groups: low, medium and high complexity procedures, since there was good correlation (r = 0.41; P < 0.001) between dose-area product (DAP) and CI. CI groups were determined by an ANOVA test, and the resulting DAP and fluoroscopy time third quartiles suggested as preliminary RLs in PTCA, as a function of procedure complexity. PTCA preliminary RLs for DAP are 54, 76 and 127 Gy cm2, and 12, 20 and 27 min for fluoroscopy time, for the three CI groups.
REFERENCE LEVELS IN PTCA AS A FUNCTION OF PROCEDURE COMPLEXITY
A. Peterzol 1 *,
E. Quai 2,
R. Padovani 2,
G. Bernardi 2,
J. C. Kotre 3,
and
A. Dowling 4
2 Azienda Ospedaliera S. Maria della Misericordia, 33100 Udine, Italy
3 Regional Medical Physics Department, Newcastle General Hospital, Newcastle Upon Tyne NE4 6BE, UK
4 Medical Physics and Bioengineering Department, Saint James's Hospital, Dublin 8, Ireland
A. Peterzol, E-mail: angela.peterzol{at}insa-lyon.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Z. Brnic, T. Krpan, D. Faj, D. Kubelka, J. P. Ramac, D. Posedel, R. Steiner, V. Vidjak, V. Brnic, K. Viskovic, et al. PATIENT RADIATION DOSES IN THE MOST COMMON INTERVENTIONAL CARDIOLOGY PROCEDURES IN CROATIA: FIRST RESULTS Radiat Prot Dosimetry, October 30, 2009; (2009) ncp237v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Tsapaki, S. Kottou, S. Korniotis, N. Nikolaki, S. Rammos, and S. C. Apostolopoulou RADIATION DOSES IN PAEDIATRIC INTERVENTIONAL CARDIOLOGY PROCEDURES Radiat Prot Dosimetry, January 2, 2009; (2009) ncn313v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V TSAPAKI, P N MANIATIS, A MAGGINAS, V VOUDRIS, S PATSILINAKOS, T VRANZTA, E VANO, and D S COKKINOS What are the clinical and technical factors that influence the kerma-area product in percutaneous coronary intervention? Br. J. Radiol., December 1, 2008; 81(972): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mavrikou, S. Kottou, V. Tsapaki, and V. Neofotistou HIGH PATIENT DOSES IN INTERVENTIONAL CARDIOLOGY DUE TO PHYSICIANS' NEGLIGENCE: HOW CAN THEY BE PREVENTED? Radiat Prot Dosimetry, March 12, 2008; (2008) ncn005v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Faulkner The DIMOND project and its impact on radiation protection Radiat Prot Dosimetry, December 1, 2005; 117(1-3): 3 - 6. [Abstract] [Full Text] [PDF] |
||||

